InvestSMART

Prescient Therapeutics Limited (ASX: PTX) - Announcements

- Current share price for PTX : $0.065

ASX company news and announcements for Prescient Therapeutics Limited (PTX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Prescient Therapeutics Limited (PTX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Prescient Therapeutics Limited (PTX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Prescient Therapeutics Limited (PTX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$74 December 2023 Quarterly Update and Appendix 4C 31 Jan 2024 11:52AM $0.056 $0.065 risen by 16.07%
$74 PTX-100 Spotlight Presentation 18 Dec 2023 10:53AM $0.070 $0.065 fallen by 7.14%
$74 PTX-100 Ph1b results show excellent safety & efficacy in TCL 11 Dec 2023 8:32AM $0.090 $0.065 fallen by 27.78%
$74 Prescient Receives $2.4 Million R&D Tax Rebate 28 Nov 2023 9:20AM $0.078 $0.065 fallen by 16.67%
$74 Results of Annual General Meeting 16 Nov 2023 5:53PM $0.069 $0.065 fallen by 5.80%
$74 Chair and CEO AGM Presentation 16 Nov 2023 12:00PM $0.079 $0.065 fallen by 17.72%
$74 PTX-100 abstract published online on ASH website 6 Nov 2023 9:28AM $0.058 $0.065 risen by 12.07%
$74 September 2023 Quarterly Update and Appendix 4C 31 Oct 2023 9:38AM $0.057 $0.065 risen by 14.04%
$74 PTX results to be presented at world's largest blood meeting 17 Oct 2023 9:17AM $0.056 $0.065 risen by 16.07%
$74 Notice of Annual General Meeting/Proxy Form 13 Oct 2023 1:56PM $0.060 $0.065 risen by 8.33%
$74 Application for quotation of securities - PTX 31 Aug 2023 1:54PM $0.080 $0.065 fallen by 18.75%
$74 Section 708A Cleansing Notice 31 Aug 2023 1:52PM $0.080 $0.065 fallen by 18.75%
$74 Appendix 4G and Corporate Governance Statement 25 Aug 2023 9:15AM $0.072 $0.065 fallen by 9.72%
$74 Appendix 4E and 2023 Annual Report 25 Aug 2023 9:07AM $0.072 $0.065 fallen by 9.72%
$74 June 2023 Quarterly Update and Appendix 4C 27 Jul 2023 9:07AM $0.076 $0.065 fallen by 14.47%
$74 Application for quotation of securities - PTX 14 Jun 2023 3:38PM $0.085 $0.065 fallen by 23.53%
$74 Two PTX abstracts accepted at prestigious ISCT conference 16 May 2023 8:59AM $0.085 $0.065 fallen by 23.53%
$74 Initial Director's Interest Notice 15 May 2023 2:31PM $0.085 $0.065 fallen by 23.53%
$74 Notification regarding unquoted securities - PTX 15 May 2023 2:30PM $0.085 $0.065 fallen by 23.53%
$74 Experienced Pharma Executive Joins Prescient Board 15 May 2023 1:56PM $0.085 $0.065 fallen by 23.53%
$74 Notification of cessation of securities - PTX 5 May 2023 10:44AM $0.098 $0.065 fallen by 33.67%
$74 Change of Director's Interest Notices x3 2 May 2023 3:53PM $0.100 $0.065 fallen by 35%
$74 Application for quotation of securities - PTX 1 May 2023 12:44PM $0.100 $0.065 fallen by 35%
$74 Section 708A Cleansing Notice 1 May 2023 12:43PM $0.100 $0.065 fallen by 35%
$74 March 2023 Quarterly Update and Appendix 4C 28 Apr 2023 9:12AM $0.093 $0.065 fallen by 30.11%

126 - 150 of 594 results

Page 6 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.